---
title: "45756.HK (45756.HK) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/45756.HK/news.md"
symbol: "45756.HK"
name: "45756.HK"
parent: "https://longbridge.com/zh-CN/quote/45756.HK.md"
datetime: "2026-03-14T22:42:24.161Z"
locales:
  - [en](https://longbridge.com/en/quote/45756.HK/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/45756.HK/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/45756.HK/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/45756.HK/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/45756.HK/news.md)


# 45756.HK (45756.HK) — 相关新闻

### [](https://longbridge.com/zh-CN/news/276571423.md)
*2026-02-23T07:04:32.000Z*
> Renault Group acquires 100% equity of Flexis

### [Waverise Investments Limited entered into the Agreement to acquire 56.45% stake in Novartis India Limited from Novartis AG for INR 12 billion.](https://longbridge.com/zh-CN/news/276384749.md)
*2026-02-19T21:55:55.000Z*
> Waverise Investments Limited has agreed to acquire a 56.45% stake in Novartis India Limited from Novartis AG for INR 12 

### [Novartis Vanrafia® Phase III data support slowing of kidney function decline](https://longbridge.com/zh-CN/news/275858389.md)
*2026-02-13T06:31:29.000Z*
> Novartis Vanrafia® Phase III data support slowing of kidney function decline

### [Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S. -- Update](https://longbridge.com/zh-CN/news/274804444.md)
*2026-02-04T11:40:55.000Z*
> Novartis forecasts a decline in core operating profit for 2026 due to increased competition from generic drugs in the U.

### [](https://longbridge.com/zh-CN/news/274761463.md)
*2026-02-04T06:01:00.000Z*
> In the fourth quarter, Novartis reported a net profit of $2.4 billion